𝔖 Bobbio Scriptorium

✦ LIBER ✦

Vinorelbine first choice for NSCLC in Italy based on cost

Book ID: 120854764
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2005
Weight: 142 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200514790-00004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN44 TREATMENT COSTS OF GRADE 3/4 ADVER

PCN44 TREATMENT COSTS OF GRADE 3/4 ADVERSE EVENTS RELATED TO FIRST-LINE THERAPY WITH BEVACIZUMAB PLUS CHEMOTHERAPY VERSUS CETUXIMAB PLUS CISPLATIN/VINORELBINE FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN SPAIN

✍ J de Castro Carpeño; K Banz; AJ Castro 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PCN43 THE COST OF TREATING GRADE 3/4 ADV

PCN43 THE COST OF TREATING GRADE 3/4 ADVERSE EVENTS RELATED TO FIRST-LINE THERAPY WITH BEVACIZUMAB PLUS CHEMOTHERAPY VERSUS CETUXIMAB PLUS CISPLATIN/VINORELBINE FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN FRANCE

✍ C Chouaid; A Vergnenegre; M Brunner; S Walzer 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PCN46 COST SAVINGS RELATED TO SUPERIOR A

PCN46 COST SAVINGS RELATED TO SUPERIOR ADVERSE EVENT PROFILE OF BEVACIZUMAB PLUS CHEMOTHERAPY VERSUS CETUXIMAB PLUS CISPLATIN/VINORELBINE IN THE FIRST-LINE THERAPY OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN GERMANY: A SENSITIVITY ANALYSIS ON THE ECOG STATUS

✍ D Heigener; HG Bischoff; K Banz; S Walzer 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PCV72 COST/UTILITY ANALYSIS (CUA) OF VAL

PCV72 COST/UTILITY ANALYSIS (CUA) OF VALSARTAN FOR THE TREATMENT OF CONGESTIVE HEART FAILURE (CHF) IN ITALY BASED ON THE VAL-HEFT TRIAL

✍ L Pradelli; S Iannazzo; O Zaniolo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

PCN88 Cost-Effectiveness Analysis Per Li

PCN88 Cost-Effectiveness Analysis Per Life-Year Gained Based on Predictors of Response for First Line Metastasic Colorectal Cancer Therapy in Spain

✍ C. Belda-Iniesta; V. Moreno; B. Martínez-Amores; J. Barriuso; L. Mezquita; I. Ib 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN67 LOWER ADMINISTRATION COSTS OF BEVA

PCN67 LOWER ADMINISTRATION COSTS OF BEVACIZUMAB IN COMBINATION WITH PLATINUM-BASED CHEMOTHERAPY VERSUS CETUXIMAB-VINORELBINE-CISPLATIN THERAPY FOR THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER (MNSCLC) FOCUSING ON THREE EUROPEAN HEALTH CARE SYSTEMS

✍ H Rosery; C Castro de; H Bischoff; D Heigener; A Vergnenegre; C Chouaid; S Walze 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB